Figure 3From: Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer 89 Zr-Cetuximab timeline. Day −3 is three days before the first day of treatment. Between day −14 and −7, further pre-treatment evaluation is performed and the treatment planning is finalized.Back to article page